Evidence map›Paper›PMID 28868518›Full record

ArticleBlood advances2017

Associations of α-thalassemia and BCL11A with stroke in Nigerian, United States, and United Kingdom sickle cell anemia cohorts.

Santosh L Saraf, Titilola S Akingbola, Binal N Shah, Chinedu A Ezekekwu, Omowunmi Sonubi, Xu Zhang, Lewis L Hsu, Mark T Gladwin, Roberto F Machado, Richard S Cooper and 2 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Blood advances, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02149537 (Risk Stratification for Clinical Severity of Sickle Cell Disease in Nigeria and Assessment of Efficacy and Safety During Treatment With Hydroxyurea), which is not on this map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02149537 phase4completednot on this map

Risk Stratification for Clinical Severity of Sickle Cell Disease in Nigeria and Assessment of Efficacy and Safety During Treatment With Hydroxyurea

TypeinterventionalSponsorLoyola UniversityRan2014 to 2022Enrolled53ConditionsSickle Cell Disease, Sickle Cell AnemiaArmshydroxyurea
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Genetic modifiers of long-term survival in sickle cell anemia.Clinical and translational medicine · 2020
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Santosh L SarafDivision of Hematology & Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL USA.
Titilola S AkingbolaDepartment of Hematology, University College Hospital, Ibadan, Nigeria.
Binal N ShahDivision of Hematology & Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL USA.
Chinedu A EzekekwuDepartment of Hematology, University College Hospital, Ibadan, Nigeria.
Omowunmi SonubiDepartment of Hematology, University College Hospital, Ibadan, Nigeria.
Xu ZhangDivision of Hematology & Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL USA.
Lewis L HsuDivision of Hematology & Oncology, Department of Pediatrics, University of Illinois at Chicago, Chicago, IL USA.
Mark T GladwinPittsburgh Heart, Lung, Blood and Vascular Medicine Institute, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA USA.
Roberto F MachadoDivision of Pulmonary & Critical Care, Department of Medicine, University of Illinois at Chicago, Chicago, IL USA.
Richard S CooperDepartment of Public Health Sciences, Loyola University Chicago Stritch School of Medicine, Maywood, IL USA.
Victor R GordeukDivision of Hematology & Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL USA.
Bamidele O TayoDepartment of Public Health Sciences, Loyola University Chicago Stritch School of Medicine, Maywood, IL USA.
University of Illinois Chicago · USUniversity College Hospital, Ibadan · NGLoyola University Chicago · USUniversity of Pittsburgh · US

Funding

Vascular Targeting Genomic & Genetic Strategies for Acute Chest SyndromeR01HL111656 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI Roberto F. Machado · 2013 to 2026
$7.9M
Role of Sphingolipid Pathways in the Pathobiology of PAHR01HL127342 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MACHADO, ROBERTO F., NATARAJAN, VISWANATHAN · 2016 to 2023
$4.5M
Stroke and Cardiovascular Research Training (SCaRT) InstituteD43TW009140 · FIC · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADANU, RICHARD M K, ALABI, SULYMAN BIODUN · 2011 to 2023
$2.5M
Genetics and Genomics of Sickle Cell Nephropathy.K23HL125984 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SARAF, SANTOSH · 2015 to 2018
$700k
Doris Duke Charitable Foundation 2013140FIC NIH HHS D43 TW009140NHLBI NIH HHS K23 HL125984NHLBI NIH HHS R01 HL111656NHLBI NIH HHS R01 HL127342
6 · The paper itself

Abstract

Alpha-thalassemia and the

Indexed as

BCL11ASickle cell anemiastrokeα-thalassemia

Identifiers

PMID28868518
PMCPMC5580997
OpenAlexW2607789570

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.